On August 21, 2019 Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, reported that the Company will participate in two investor conferences on September 5. Jigar Raythatha, CEO, will meet with investors at the Citi 14th Annual Biotech Conference at the Four Seasons Hotel in Boston (Press release, Constellation Pharmaceuticals, AUG 21, 2019, View Source [SID1234538930]). Emma Reeve, CFO, will present at the Baird Global Healthcare Conference at the InterContinental Hotel in New York at 11:25 am EDT. A live audio webcast of Ms. Reeve’s presentation and an archive for replay will be available on the Investor Relations section of Constellation’s website at View Source The audio webcast replay will be available for 90 days following the live presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!